Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

HMGB1 Promotes the Synthesis of Pro-IL-1β and Pro-IL-18 by Activation of p38 MAPK and NF-κB Through Receptors for Advanced Glycation End-products in Macrophages

  • He, Qiang (Institute of Integrated Traditional Medicine and Western Medicine, Beijing Friendship Hospital, Capital Medical University) ;
  • You, Hong (Liver Research Center, Beijing Friendship Hospital, Capital Medical University) ;
  • Li, Xin-Min (Liver Research Center, Beijing Friendship Hospital, Capital Medical University) ;
  • Liu, Tian-Hui (Liver Research Center, Beijing Friendship Hospital, Capital Medical University) ;
  • Wang, Ping (Liver Research Center, Beijing Friendship Hospital, Capital Medical University) ;
  • Wang, Bao-En (Institute of Integrated Traditional Medicine and Western Medicine, Beijing Friendship Hospital, Capital Medical University)
  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

The high mobility group box-1 (HMGB1) protein and NALP3 inflammasome have been identified to play important roles in inflammation and cancer pathogenesis, but the relationships between the two and cancer remain unclear. The current study investigated the relationship between HMGB1 and the NALP3 inflammasome in THP-1 macrophages. HMGB1 was found unable to activate the NALP3 inflammasome and failed to induce the release of the IL-$1{\beta}$ and IL-18 in THP-1 macrophages. HMGB1 was also found significantly enhanced the activity of ATP to induce IL-$1{\beta}$ and IL-18 by the induction of increased expression of pro-IL-$1{\beta}$ and pro-IL-18. This process was dependent on activation of RAGE, MAPK p38 and NF-${\kappa}B$ signaling pathway. These results demonstrate that HMGB1 promotes the synthesis of pro-IL-$1{\beta}$ and pro-IL-18 in THP-1 macrophages by the activation of p38 MAPK and NF-${\kappa}B$ through RAGE. HMGB1 likely plays an important role in the first step of the release of the IL-$1{\beta}$ and IL-18, preparing for other cytokines to induce excessive release of IL-$1{\beta}$ and IL-18 which promote inflammation and cancer progression.

Keywords

References

  1. Andersson U, Wang H, Palmblad K, et al (2000). High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 192, 565-70. https://doi.org/10.1084/jem.192.4.565
  2. Bauernfeind FG, Horvath G, Stutz A, et al (2009). Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol, 183, 787-91. https://doi.org/10.4049/jimmunol.0901363
  3. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44. https://doi.org/10.1038/nature07205
  4. Carrascal MT, Mendoza L, Valcarcel M, et al (2003). Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res, 63, 491-7.
  5. Eissa SA, Zaki SA, El-Maghraby et al (2005). Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst, 17, 51-5.
  6. Klune JR, Dhupar R, Cardinal J, et al (2008). HMGB1: endogenous danger signaling. Mol Med, 14, 476-84.
  7. Lewis AM, Varghese S, Xu H, et al (2006). Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med, 4, 48. https://doi.org/10.1186/1479-5876-4-48
  8. Lotze MT, Tracey KJ (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol, 5, 331-42. https://doi.org/10.1038/nri1594
  9. Luan ZG, Zhang H, Yang PT, et al (2010). HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology, 215, 956-62. https://doi.org/10.1016/j.imbio.2009.11.001
  10. Martinon F (2010). Signaling by ROS drives inflammasome activation. Eur J Immunol, 40, 616-9. https://doi.org/10.1002/eji.200940168
  11. Merendino RA, Gangemi S, Ruello A, et al (2001). Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations. Int J Biol Markers, 16, 126-9.
  12. Okamoto M, Liu W, Luo Y, et al (2010). Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem, 285, 6477-88. https://doi.org/10.1074/jbc.M109.064907
  13. Park JS, Gamboni-Robertson F, He Q, et al (2006). High mobility group box 1 protein interacts with multiple Tolllike receptors. Am J Physiol Cell Physiol, 290, C917-24.
  14. Schroder K, Tschopp J (2010). The inflammasomes. Cell, 140, 821-32. https://doi.org/10.1016/j.cell.2010.01.040
  15. Sha Y, Zmijewski J, Xu Z, et al (2008). HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol, 180, 2531-7. https://doi.org/10.4049/jimmunol.180.4.2531
  16. Sims GP, Rowe DC, Rietdijk ST, et al (2010). HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol, 28, 367-88. https://doi.org/10.1146/annurev.immunol.021908.132603
  17. Tang D, Kang R, 3rd ZHJ, et al (2010). High-mobility group box 1 and cancer. Biochim Biophys Acta, 1799, 131-40. https://doi.org/10.1016/j.bbagrm.2009.11.014
  18. Tschopp J, Schroder K (2010). NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production. Nat Rev Immunol, 10, 210-5. https://doi.org/10.1038/nri2725
  19. Wang P, Cong M, Liu TH, et al (2010). Primary isolated hepatic oval cells maintain progenitor cell phenotypes aftertwo-year prolonged cultivation. J Hepatol, 53, 863-71. https://doi.org/10.1016/j.jhep.2010.05.014
  20. Yang D, Chen Q, Yang H, et al (2007). High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol, 81, 59-66.
  21. Yang J, Chen L, Yang J, et al (2011). High mobility group box- 1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep, 39, 3361-7.
  22. Ye ZB, Ma T, Li H, et al (2007). Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol, 13, 1747-51. https://doi.org/10.3748/wjg.v13.i11.1747

Cited by

  1. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke vol.4, pp.9, 2013, https://doi.org/10.1038/cddis.2013.326
  2. S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-κB1 vol.8, pp.8, 2013, https://doi.org/10.1371/journal.pone.0072138
  3. The Emerging Role of the Receptor for Advanced Glycation End Products on Innate Immunity vol.33, pp.1, 2014, https://doi.org/10.3109/08830185.2013.849702
  4. The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines vol.390, pp.1-2, 2014, https://doi.org/10.1007/s11010-014-1978-6
  5. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling vol.54, pp.12, 2014, https://doi.org/10.1002/mc.22231
  6. Microglia centered pathogenesis in ALS: insights in cell interconnectivity vol.8, pp.1662-5102, 2014, https://doi.org/10.3389/fncel.2014.00117
  7. Potential role of High mobility group box 1 in hepatocellular carcinoma vol.8, pp.5, 2014, https://doi.org/10.4161/19336918.2014.969139
  8. Adrenergic stimulation alters the expression of inflammasome components and interleukins in primary human monocytes vol.11, pp.1, 2015, https://doi.org/10.3892/etm.2015.2850
  9. HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients vol.13, pp.1, 2015, https://doi.org/10.1186/s12967-015-0663-1
  10. B cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice vol.24, pp.6, 2015, https://doi.org/10.1111/exd.12685
  11. Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells vol.67, pp.5, 2015, https://doi.org/10.1002/iub.1379
  12. Production vol.2016, pp.1466-1861, 2016, https://doi.org/10.1155/2016/5460302
  13. Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development vol.241, pp.3, 2016, https://doi.org/10.1002/path.4848
  14. Low-level light emitting diode (LED) therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke vol.10, pp.11, 2017, https://doi.org/10.1002/jbio.201600244
  15. NLRP3 inflammasome: Its regulation and involvement in atherosclerosis vol.233, pp.3, 2018, https://doi.org/10.1002/jcp.25930
  16. Leukocytapheresis for the treatment of acute exacerbation of idiopathic interstitial pneumonias: a pilot study vol.64, pp.1.2, 2017, https://doi.org/10.2152/jmi.64.110
  17. Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease vol.9, pp.4, 2017, https://doi.org/10.3390/nu9040385
  18. Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke pp.1559-1182, 2017, https://doi.org/10.1007/s12035-017-0394-9
  19. Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector? vol.22, pp.13, 2015, https://doi.org/10.1089/ars.2014.5994
  20. HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome vol.9, pp.1664-042X, 2018, https://doi.org/10.3389/fphys.2018.00313
  21. Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance vol.2018, pp.1942-0994, 2018, https://doi.org/10.1155/2018/4321714